- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 477/12 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycinsSuch ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
Patent holdings for IPC class C07D 477/12
Total number of patents in this class: 4
10-year publication summary
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| JW Pharmaceutical Corporation | 81 |
2 |
| University of Notre Dame du Lac | 601 |
1 |
| Washington University | 1729 |
1 |
| Other owners | 0 |